Clinical Trial

A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, open-label and dose-escalation study to evaluate the safety, tolerability and dose-response relationship of HRS-9190 in healthy adults.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-10; most recent amendment 2026-03-05.
Status change: Recruiting → Completed 2025-08-20
Status change: Not Yet Recruiting → Recruiting 2025-06-20
Trial Details
NCT Number NCT06932315
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Skeletal Muscle Relaxation
Enrollment 53 participants
Start Date 2025-04-23
Primary Completion 2025-08-13 (estimated)
Study Completion 2025-08-13 (estimated)
Updated on ClinicalTrials.gov 2026-03-06